Merav Beiman

USPTO Granted Patents = 10 (Patent Applications = 15)

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 8 (Patent Applications = 15)

Average Co-Inventor Count = 10.0

ph-index = 3

Forward Citations = 23(Granted Patents)

Location History:

Nes Ziona, IL (2009 - 2015)
Tel Aviv-Jaffa, IL (2017)
Tel Aviv, IL (2018)
Ness Ziona, IL (2010 - 2023)

Company Filing History:

9 out of 60

Compugen Ltd. Corporation

Gavish-galilee Bio Applications Ltd.

patents

where one patent can have more than one assignee

Years Active: 2009-2023

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11660315 - Universal platform for preparing an inhibitory chimeric antigen receptor (iCAR) (2023-05-30),

2. 10098934 - Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics (2018-10-16),

3. 9555087 - Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics (2017-01-31),

4. 9375466 - Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics (2016-06-28),

5. 9107862 - Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics (2015-08-18),

6. 8415455 - Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics (2013-04-09),

7. 8349801 - Peptide ligands for G-protein coupled receptors (2013-01-08),

8. 7758862 - Hepatocyte growth factor receptor splice variants and methods of using same (2010-07-20),

9. 7678769 - Hepatocyte growth factor receptor splice variants and methods of using same (2010-03-16),

10. 7601692 - MCP-1 splice variants and methods of using same (2009-10-13),

Certainly! Here is the article about inventor Merav Beiman:

Title: The Trailblazing Innovations of Merav Beiman

Introduction:

Merav Beiman stands as a beacon of innovation, reshaping the landscape of technology with his unwavering dedication to excellence. His remarkable journey as an inventor has not only yielded impactful patents but has also inspired a generation of aspiring inventors worldwide.

Latest Patents:

Merav Beiman's latest patents showcase his pioneering spirit in revolutionizing the field of biotechnology. One of his groundbreaking inventions includes a "Universal Platform for Preparing an Inhibitory Chimeric Antigen Receptor (iCAR)", offering a novel method for identifying targets to prevent or diminish undesired activation of effector immune cells. Another notable patent involves "Polypeptides and Polynucleotides for Drug Targeting", which presents innovative therapeutic antibodies against various antigens for cancer treatment and immunotherapy.

Career Highlights:

With an impressive portfolio of 10 patents to his name, Merav Beiman has demonstrated a relentless pursuit of innovation. Having worked with renowned companies such as Compugen Ltd. and Immpact-bio Ltd., he has left an indelible mark on the biotechnology industry. His contributions continue to drive advancements in disease diagnosis, drug development, and immunotherapy.

Collaborations:

Merav Beiman's collaborative efforts with esteemed colleagues Zurit Levine and Galit Rotman have further accelerated the pace of innovation. Together, they have synergized their expertise to create cutting-edge solutions that address critical challenges in healthcare and biotechnology.

Conclusion:

In conclusion, Merav Beiman's passion for innovation and his trailblazing inventions underscore his significant impact on the future of technology. As a visionary inventor, he not only shapes the present landscape but also paves the way for a brighter, more innovative tomorrow. His legacy serves as a source of inspiration for all aspiring inventors, driving them to push boundaries and redefine what is possible in the realm of technology.

This text is generated by artificial intelligence and may not be accurate.